Cyclosporine A: peak or trough level monitoring in renal transplant recipients?

By Wacke R.   Drewelow B.   Kundt G.   Hehl E.-M.   Bast R.   Seiter H.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3122-3123

Elsevier

Access to resources Recommend Favorite

Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients

By Marcen R.   Pascual J.   Tato A.   Villafruela J.J.   Teruel J.L.   Rivera M.E.   Tenorio M.   Fernandez M.   Burgos F.J.   Ortuno J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1780-1782

Elsevier

Access to resources Recommend Favorite

Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C 0 ) and C 2 concentrations in stable renal allograft recipients

By Einecke G.   Mai I.   Diekmann F.   Fritsche L.   Boehler T.   Neumayer H.-H.   Budde K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3102-3103

Elsevier

Access to resources Recommend Favorite

Optimization of cyclosporine exposure utilizing C 2 level monitoring in de novo renal transplant recipients: the toronto general hospital experience

By Maham N.   Cardella C.   Cattran D.   Fenton S.   O'Grady C.   Hamill J.   Smith R.   Cole E.   Multi-Organ Transplant Program  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3098-3099

Elsevier

Access to resources Recommend Favorite

clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients

By Barakat O.   Peaston R.   Rai R.   Talbot D.   Manas D.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1535-1537

Elsevier

Access to resources Recommend Favorite